Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 3 days · Every feed →

All 13Congress 0Executive branch 0Insiders 13
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TRDA · Insiders · $1M+ · 13 trades

Trades
13
Buys 0 · Sells 13
People
13
Stocks
1
Disclosed value
$18.5M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  2. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  3. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  4. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  5. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  7. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  8. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  9. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  10. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  11. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  12. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  13. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade